![Harry Lander](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Harry Lander
Verkställande Direktör på
Canary Oncoceutics, Inc.
Förmögenhet: - $ per 2026-09-30
Profil
Harry M.
Lander is currently the Chief Executive Officer at Canary Oncoceutics, Inc., the Director at Federation Employment & Guidance Service, Inc., and the Director at Capo Therapeutics, Inc. Previously, he held the position of President, Director & Chief Scientific Officer at Zander Therapeutics, Inc. from 2018 to 2019, and President & Chief Scientific Officer at Regen Biopharma, Inc. from 2015 to 2019.
He also served as the Head-Administration at Sidra Medical & Research Center.
In addition, he will be the Chief Scientific Officer at SYBLEU, Inc. from 2022 to 2024.
Dr. Lander obtained his undergraduate degree from Stony Brook University.
He also holds an MBA from The Leonard N Stern School of Business, which he received in 1991.
Furthermore, he earned a doctorate degree from Weill Cornell Graduate School of Medical Sciences in 1992.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
REGEN BIOPHARMA, INC. 22,72 % | 2025-11-10 | 6 667 ( 22,72 % ) | - $ | 2026-09-30 |
REGEN BIOPHARMA, INC. 1,03 % | 2025-11-10 | 20 020 001 ( 1,03 % ) | - $ | 2026-09-30 |
Aktiva positioner av Harry Lander
| Företag | Position | Start |
|---|---|---|
Federation Employment & Guidance Service, Inc.
 Federation Employment & Guidance Service, Inc. Services to the Health IndustryHealth Services Provides health and human services | Direktör/Styrelseledamot | 2009-09-16 |
Capo Therapeutics, Inc.
 Capo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops peptide and epitope vaccines for alzheimer's disease | Direktör/Styrelseledamot | - |
Canary Oncoceutics, Inc.
 Canary Oncoceutics, Inc. BiotechnologyHealth Technology Develops precision oncology testing platform | Verkställande Direktör | - |
Tidigare kända positioner av Harry Lander
| Företag | Position | Slut |
|---|---|---|
| SYBLEU INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-04-12 |
| REGEN BIOPHARMA, INC. | President | 2019-01-22 |
Zander Therapeutics, Inc.
 Zander Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for cancer | President | 2019-01-22 |
Sidra Medical & Research Center
 Sidra Medical & Research Center Miscellaneous Commercial ServicesCommercial Services Operates as a medical research organisation | Administrativ Direktör | - |
Harry Landers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
81
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Regen Biopharma, Inc.
 Regen Biopharma, Inc. BiotechnologyHealth Technology Develops regenerative medicine therapies and tools | Health Technology |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Federation Employment & Guidance Service, Inc.
Federation Employment & Guidance Service, Inc. Services to the Health IndustryHealth Services Provides health and human services | Health Services |
Sidra Medical & Research Center
Sidra Medical & Research Center Miscellaneous Commercial ServicesCommercial Services Operates as a medical research organisation | Commercial Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Graduate School of Medical Sciences
 Weill Cornell Graduate School of Medical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zander Therapeutics, Inc.
Zander Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for cancer | Health Technology |
Capo Therapeutics, Inc.
Capo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops peptide and epitope vaccines for alzheimer's disease | Health Technology |
SYBLEU, Inc.
 SYBLEU, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an early-stage company which intends to develop regenerative medical applications | Commercial Services |
Canary Oncoceutics, Inc.
Canary Oncoceutics, Inc. BiotechnologyHealth Technology Develops precision oncology testing platform | Health Technology |
